Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy

Cancer is one of the deadliest diseases, causing million of deaths each year globally. Conventional anti-cancer therapies are non-targeted and have systemic toxicities limiting their versatile applications in many cancers. So, there is an unmet need for more specific therapeutic options that will be...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Devesh, Yang, Jie, Salam, Md. Abdus, Sengupta, Sagnik, Al-Amin, Md. Yusuf, Mustafa, Saad, Khan, Mohammad Aasif, Huang, Xun, Pawar, Jogendra Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475555/
https://www.ncbi.nlm.nih.gov/pubmed/37671162
http://dx.doi.org/10.3389/fimmu.2023.1203073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475555/
https://www.ncbi.nlm.nih.gov/pubmed/37671162
http://dx.doi.org/10.3389/fimmu.2023.1203073

Ejemplares similares